Table 5. . Management of BRAFV600 inhibitor toxicities.
Toxicity | Management |
---|---|
Skin toxicities | |
Rash | Diphehydramine 25–50 mg po q6h prn |
Hydrorxyzine 25–50 mg po q6h prn | |
Urea 10–22% loc appl prn | |
Hydrating cream loc appl prn | |
Hydrocortisone 1% or betamethasone 0.1% loc appl prn | |
Photosensitivity | Protective clothing, avoid sunlight |
Sun block of at least 30 SPF | |
Secondary malignancies | |
Squamous cell skin cancer | Close follow-up by dermatologist |
Keratoacanthoma | |
Gastrointestinal | |
Diarrhea | Loperamide 2 mg po prn max 16 mg/day |
Diphenoxylate/atropine 1–2 tabs po q6–8h prn | |
Nausea, vomiting | Metoclopramide 10 mg po q6h prn |
Prochlorperazin 10 mg po/pr q6h prn | |
Musculoskeletal | |
Arthralgia | Acetaminophen 325–650 mg po q4–6h prn |
Ibuprofen 200–400 mg po q6h prn† |
†Or equivalent.
po: Per os; Prn: If needed; q6h: Every 6 h; SPF: Sun protection factor.